EGFR and small cell lung carcinoma: Aberrant signaling driven by epidermal growth factor receptor (EGFR), stem cell factor receptor tyrosine kinase (c-KIT), PI3K/AKT/mTOR, insulin-like growth factor receptor (IGFR1), and hedgehog signaling pathways have been identified in SCLC.